Literature DB >> 3396485

Optimal duration of cefotaxime prophylaxis in abdominal and vaginal hysterectomy.

P J McDonald1, R Sanders, J Turnidge, P Hakendorf, P Jolley, H McDonald, O Petrucco.   

Abstract

Previous studies have demonstrated that short course perioperative antibiotic prophylaxis reduces septic morbidity after hysterectomy from up to 40% down to 10 to 15%. The residual morbidity is predominantly urinary tract infection (UTI) occurring 2 to 3 days after cessation of antibiotic. We hypothesised that surgery impairs urinary drainage for 3 to 4 days postoperatively and that prolonged prophylaxis was required to prevent all postoperative sepsis. Accordingly, 224 abdominal and 69 vaginal hysterectomy patients were randomly allocated to short course (2g cefotaxime IV at anaesthesia) or long course (2g cefotaxime at anaesthesia plus 7 doses of 1g 12-hourly) prophylaxis. UTI was effectively prevented by the long course (0.9 vs 18.4% short); both treatments effectively prevented wound and pelvic sepsis. We conclude that 4 days of postoperative antibiotic is required to prevent UTI.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3396485     DOI: 10.2165/00003495-198800352-00048

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  4 in total

1.  Diagnostic criteria and natural history of catheter-associated urinary tract infections after prostatectomy.

Authors:  D L Gordon; P J McDonald; A Bune; V R Marshall; B Grime; J Marsh; G Sinclair
Journal:  Lancet       Date:  1983-12-03       Impact factor: 79.321

2.  Antimicrobial prophylaxis: a critique of recent trials.

Authors:  J V Hirschmann; T S Inui
Journal:  Rev Infect Dis       Date:  1980 Jan-Feb

3.  Antibiotic prophylaxis in hysterectomy--cefotaxime compared to ampicillin-tinidazole.

Authors:  P J McDonald; T Sanders; G Higgins; L Finlay-Jones; M Hakendorf; J Turnidge; W Jones
Journal:  J Antimicrob Chemother       Date:  1984-09       Impact factor: 5.790

4.  Complications of abdominal and vaginal hysterectomy among women of reproductive age in the United States. The Collaborative Review of Sterilization.

Authors:  R C Dicker; J R Greenspan; L T Strauss; M R Cowart; M J Scally; H B Peterson; F DeStefano; G L Rubin; H W Ory
Journal:  Am J Obstet Gynecol       Date:  1982-12-01       Impact factor: 8.661

  4 in total
  5 in total

1.  Antibiotic prophylaxis in vaginal hysterectomy. Three doses of cefuroxime plus metronidazole versus one dose of ciprofloxacin.

Authors:  W K Brouwer; J A Hoogkamp-Korstanje; K M Kuiper
Journal:  Pharm Weekbl Sci       Date:  1990-12-14

Review 2.  Antibiotic prophylaxis for elective hysterectomy.

Authors:  Reuben Olugbenga Ayeleke; Selma Mourad; Jane Marjoribanks; Karim A Calis; Vanessa Jordan
Journal:  Cochrane Database Syst Rev       Date:  2017-06-18

3.  Randomized, double-blind comparison of the efficacies, costs, and vaginal flora alterations with single-dose ceftriaxone and multidose cefazolin prophylaxis in vaginal hysterectomy.

Authors:  H G Stiver; B O Binns; R C Brunham; N Cheng; D M Dean; A M Goldring; J B Walker; E Tan; J McLeod
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

Review 4.  Antibiotic prophylaxis in hysterectomy and induced abortion. A review of the evidence.

Authors:  E T Houang
Journal:  Drugs       Date:  1991-01       Impact factor: 9.546

5.  Postoperative urinary tract infections (UTIs) following single-dose intraoperative antibiotic prophylaxis in colposuspension patients.

Authors:  V N Chilaka; C J Mayne
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  1998
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.